Jaipur, 19 September, 2024.

The Indian Society for Inborn Errors of Metabolism (ISIEM) proudly announces its highly anticipated National Conference on Inborn Errors of Metabolism (ISIEM 2024), scheduled from September 20-22, 2024, at the Rajasthan International Centre, Jaipur. This event will serve as a crucial platform for experts, clinicians, researchers, and families affected by Inherited Metabolic Disorders (IMDs) to exchange knowledge, innovations, and best practices in this rapidly evolving field.

Dr.Priyanshu Mathur, Secretary, ISIEM, while addressing the media said, “ The conference will focus on the latest advances in the diagnosis, management, and treatment of IMDs. IMDs, a group of rare but critical genetic disorders, affect the body's ability to metabolize nutrients into energy. If left undiagnosed or untreated, these conditions can lead to significant developmental, intellectual, and physical disabilities, including seizures and, in severe cases, early death. Defects in enzymes, hormones, or other essential molecules involved in metabolic processes are the root causes of IMDs.

Talking about discussions to be held in this three-day conference, Dr. Lokesh Aggarwal, Treasurer, ISIEM 2024 gave some point-wise information and said that:

•           Newborn Screening and Early Diagnosis: Exploring the importance of early detection through nationwide screening programs to improve outcomes and prevent irreversible damage.

•           Advances in Genetic Testing and Counseling: Examining breakthroughs in genetic diagnostics, providing precise identification of IMDs, and offering personalized counseling to families.

•           Novel Therapies and Treatments: Delving into cutting-edge therapeutic options, such as enzyme replacement therapy, gene therapy, and other evolving interventions that are transforming IMD management.

•           Management of Complications and Co-morbidities: Addressing holistic patient care, including strategies for managing complications like organ dysfunction, neurological issues, and long-term metabolic management.

•           Patient and Family Support and Advocacy: Empowering patients and caregivers by strengthening networks for support, guidance, and advocacy.

Dr. Jaikishan Mittal, Chairman ISIEM said that Phenylketonuria (PKU), Galactosemia, Glycogen Storage Disorders, Mucopolysaccharidoses, Lysosomal Storage Disorders will also be discussed in this conference.

Dr. Manisha Goyal, Coordinator, ISIEM said that Scientific Sessions will include presentations of cutting-edge research and clinical case studies by leading experts. Panel Discussions and Debates will also includeinteractive discussions focusing on current challenges, controversies, and future directions in IMD treatment and policy.

Similarly workshops and training programs will include hands-on sessions for healthcare professionals, offering training in genetic counseling, diagnostic techniques, and the latest therapeutic interventions.

Objectives of ISIEM 2024

The conference aims to:

•           Educate Healthcare Professionals: Equip clinicians, geneticists, and allied healthcare providers with the latest knowledge and skills in diagnosing and treating IMDs.

•           Promote Research and Collaboration: Provide a platform for researchers to share their findings, engage in collaborative discussions, and explore new avenues of research that could lead to transformative breakthroughs.

•           Support Families and Patients: Advocate for early diagnosis, better treatment access, and comprehensive support networks for families affected by IMDs, helping them navigate the complexities of these disorders.